The enzyme as drug: application of enzymes as pharmaceuticals

This publication has 43 references indexed in Scilit:

• Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha
  Thorax, 2002
• Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase
  Journal of Neuroscience Research, 2002
• Fabry disease: recent advances in enzyme replacement therapy
  Expert Opinion on Investigational Drugs, 2002
• Dornase alfa in early cystic fibrosis lung disease
  Pediatric Pulmonology, 2002
• Wild-Type and A328W Mutant Human Butyrylcholinesterase Tetramers Expressed in Chinese Hamster Ovary Cells Have a 16-Hour Half-Life in the Circulation and Protect Mice from Cocaine Toxicity
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Expression System for High Levels of GAG Lyase Gene Expression and Study of the hepA Upstream Region in Flavobacterium heparinum
  Journal of Bacteriology, 2002
• A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study
  Blood, 2002
• PEG drugs: an overview
  Journal of Controlled Release, 2001
• PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years
  Clinical Immunology and Immunopathology, 1995
• Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's Disease
  New England Journal of Medicine, 1991